ActiGraph is now providing scientific services to its clients. These service offerings help clinical trial sponsors maximize the benefits of digital health technologies (DHTs) throughout the clinical development lifecycle.
ActiGraph’s new end-to-end services, which include endpoint design, algorithm validation, biostatistical analysis, and regulatory engagement, are offered in conjunction with the company’s validated, FDA-cleared wearable technology platform. This fit-for-purpose package of solutions is designed to guide study teams through the process of study planning and implementation.
Read more about the new services
